ScanZ Company

ScanZ is an easy-to-use handheld device with advanced imaging and algorithms to identify, track, and quantify acne. The imaging device connects with a tablet/mobile application to monitor and analyse acne conditions and severity. ScanZ enables more accurate, objective diagnosis, tracking and monitoring at hospitals, clinics, or remotely from home. In the Healthcare industry, digital healthcare solutions will become vital in order to ensure a sustainable and efficient health system in both a time and cost effective manner. ScanZ aims to significantly contribute in creating innovative and sustainable principles in the Healthcare market by improving the quality of life for acne sufferers and working conditions for medical professionals. ScanZ is an innovative digital skin-care solution for acne sufferers, dermatologists, and medical practitioners, applying new sets of rules, values and model to the health-care market. Up to now, acne assessment was only possible visiting dermatologist and traditional acne assessment was a time consuming and costly procedure. Today, with ScanZ’s proprietary assessment, there are better, more objective alternatives to help the millions of acne sufferers and thousands of dermatologists. The ScanZ team is currently refining the technical readiness level to be market ready enabling the device to be clinically and commercially qualified for launch. ScanZ will be available commercially at the end of the Phase 2 grant as a medically certified, IP protected user-centric designed system to be sold to hospitals, practitioners and the community.
Technology: MarketPlace
Industry: P4 Medicine
Headquarters: Europe
Founded Date: 1998-01-01
Employees Number: 1-10
Investors Number: 1
Total Funding: €50K
Last Funding Type: Grant

Visit Website
Register and Claim Ownership